Alzheimer’s research has a diversity problem. The disease disproportionately strikes underrepresented groups, including Black and Hispanic people, but clinical trials include mostly white participants — an issue Jackson publishes on and speaks about frequently. His long-standing efforts calling out the need to understand ethnic and racial differences in Alzheimer’s and other diseases are gaining traction with ever-growing audiences. In 2022, he lectured and published widely about justice in clinical research and health equity.
Jonathan Jackson
Executive director, Community Access, Recruitment, and Engagement (CARE) Research Center at Massachusetts General Hospital and Harvard Medical School; assistant professor of neurology, Harvard Medical School
More in Academia
Academia
Alberto Ascherio
Professor of epidemiology and nutrition, Harvard T.H. Chan School of Public Health
Academia
Euan Ashley
Professor of medicine and genomics, Stanford School of Medicine
Academia
Carolyn Bertozzi
Professor of chemistry, Stanford University
Academia
Kirsten Bibbins-Domingo
Editor-in-chief, JAMA
Academia
Maria Elena Bottazzi
Co-director, Texas Children’s Hospital Center for Vaccine Development
Academia
Daniel Dawes
Executive director, Global Health Equity Institute, Meharry Medical College
Academia
Amy Finkelstein
Professor of economics, MIT
Academia
Rachel Hardeman
Director, Center for Antiracism Research for Health Equity, UMN
Academia
Akiko Iwasaki
Professor of immunobiology, Yale School of Medicine
Academia
Keaweʻaimoku Kaholokula
Chair, Native Hawaiian Health, University of Hawai‘i at Mānoa
Academia
Marc Lipsitch
Director of science, CDC Center for Forecasting and Outbreak Analytics
Academia
Valerie Montgomery Rice
President & CEO, Morehouse School of Medicine
Academia
Roderic Pettigrew
Dean, Intercollegiate School of Engineering Medicine, Texas A&M
Academia
Anne Rimoin
Professor of Epidemiology, UCLA Fielding School of Public Health
Academia
Emily Wang
Professor, Yale School of Medicine